SCHEMBL9680283

SCHEMBL9680283

CC(C)c1cccc(C(C)C)c1N(C(=O)CCl)c1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.62
NPC1 O15118 8/20 0.62
RAB9A P51151 8/20 0.62
KMT2A Q03164 7/20 0.62
HTT P42858 5/20 0.62
NPSR1 Q6W5P4 3/20 0.62
POLB P06746 1/20 0.62
SMN1; SMN2 Q16637 5/20 0.54
LMNA P02545 4/20 0.54
TP53 P04637 2/20 0.54
MAPT P10636 3/20 0.47
HKDC1 Q2TB90 1/20 0.47
MEN1 O00255 3/20 0.45
MITF O75030 3/20 0.45
TDP1 Q9NUW8 2/20 0.45
PAX8 Q06710 6/20 0.44
KDM4E B2RXH2 2/20 0.44
GLA P06280 1/20 0.43
JAK2 O60674 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2345303 0.78 ALDH1A1 (1.00) ALDH1A1NPC1RAB9AKMT2AHTT
SCHEMBL9640442 0.78 NPC1 (0.70) ALDH1A1NPC1RAB9AKMT2AHTT
SCHEMBL3159839 0.77 NLRP3 (0.41) ALDH1A1RAB9AKMT2ANPSR1POLB
SCHEMBL9723545 0.73 NPSR1 (0.47) ALDH1A1NPC1KMT2ANPSR1LMNA
SCHEMBL7339289 0.72 RAB9A (0.79) ALDH1A1NPC1RAB9AKMT2AHTT
SCHEMBL11417909 0.72 HTT (0.44) ALDH1A1NPC1RAB9AKMT2AHTT
SCHEMBL11142269 0.71 SMN1; SMN2 (0.41) ALDH1A1NPC1RAB9AKMT2AHTT
SCHEMBL28665552 0.71 ALDH1A1 (0.64) ALDH1A1NPC1RAB9AKMT2AHTT
SCHEMBL7165377 0.71 NPC1 (0.58) ALDH1A1NPC1RAB9AKMT2AHTT
SCHEMBL11872903 0.71 SMN1; SMN2 (0.43) ALDH1A1NPC1RAB9AKMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5153226-A Administering as anticholesterol agents, for atherosclerosis WARNER-LAMBERT COMPANY (US) 1992-10-06 US disclosed
EP-0415413-A1 Acat inhibitors WARNER-LAMBERT COMPANY (US) 1991-03-06 EP disclosed